Latest Lead News

Pro Medicus Limited reported a robust half-year performance, with underlying profit after tax rising by approximately 30%, driven by significant new sales and strategic implementations. The company remains confident in its proprietary technology's resilience against AI disruption while expanding its market footprint.

ASX Limited has announced a fully franked ordinary dividend of AUD 1.018 per share for the half-year ending December 2025, offering shareholders a dividend reinvestment plan with a 2.5% discount.

ASX Limited has posted a solid 8.3% increase in net profit for the half-year ending December 2025, while announcing a reduced dividend payout and the planned departure of its CEO. The company is navigating regulatory scrutiny and investing heavily in technology upgrades.

Middle Island Resources has revealed extensive polymetallic soil anomalies spanning 5km at its Tisovik target in Serbia’s Bobija Project, signalling a promising expansion of mineralisation. The company plans to intensify exploration activities starting March 2026 to unlock the area’s full potential.

International Graphite Limited has reported pilot-scale testwork results exceeding purity targets for expandable graphite, underpinning plans for a European production facility.

Marmota Limited has raised $15 million through a well-supported placement, aiming to fast-track exploration at its promising Gawler gold project. The capital injection comes with strong institutional backing and sets the stage for upcoming drilling campaigns.

Robex Resources has officially reached commercial production at its Kiniero Gold Project in Guinea, marked by a significant first shipment of over 6,300 ounces of gold. This milestone sets the stage for the company’s strategic growth and upcoming merger plans.

Lendlease CEO Tony Lombardo will step down in August 2026, marking a leadership change after five years at the helm and a significant strategic reset. The Board has begun the search for his successor as the company prepares for its next growth phase.

AMP Limited reported a 20.8% rise in underlying net profit after tax for 2025, driven by growth in wealth platforms and investments, alongside a planned CEO transition and pending class action settlements.

Entropy Neurodynamics has been granted an Australian patent for its novel two-phase IV infusion method administering psilocybin and psilocin, securing exclusive rights through 2042 and strengthening its lead asset TRP-8803’s competitive position.

South32 Limited reported a 29% rise in profit for the half year ended December 2025, driven by higher base and precious metals prices and solid operational performance. The company declared a fully-franked interim dividend and maintained its FY26 production guidance, while advancing key projects and managing portfolio transitions.

Orora has reported a strong first half for FY26 with a 32% rise in underlying net profit, driven by robust volume growth in its Cans segment and improved cash flow. The company also announced a fresh $270 million on-market share buyback, signalling confidence in its ongoing growth trajectory.